Tectonic Therapeutic Funding & Investors
Tectonic is a privately held biotechnology company that aims to transform the discovery of novel GPCR-targeted drugs and unlock the therapeutic utility the most challenging receptors in the class. Tectonic’s founders are at the forefront of scientific research in biochemistry and molecular pharmacology with an extensive track record of entrepreneurial achievement.
tectonictx.comTotal Amount Raised: $80,000,000
Tectonic Therapeutic Funding Rounds
Series A
$80,000,000
Series A Investors
Polaris PartnersTimothy SpringerVida VenturesEcoR1 Capital
Funding info provided by Diffbot.